A detailed study by Boudreault et al
In a statement released Monday, it claims that Hims has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of personalization and are disseminating deceptive marketing that put patient safety at risk. Novo says its still open to working with telehealth companies so as long as they dont engage in illegal sham compounding, and it has existing agreements with other companies, like Ro, to sell its drugs
doi:10.1111/jcpt.13259 Yang Z, Lv Y, Yu M, Mei M, Xiang L, Zhao S, et al
It is manufactured in an FDA-registered facility and meets NSF certification and GMP compliance standards
The FDA labeling for most GLP-1 receptor agonists simply says "any time of day." But that does not mean timing is irrelevant
No controlled studies have evaluated the safety or efficacy of chelation in individuals with ASD